MDMA, \u00f6forik ve empatik etkileriyle bilinen bir madde, t\u0131bbi alanda terap\u00f6tik potansiyeli nedeniyle giderek daha fazla ilgi g\u00f6rmektedir. Kontroll\u00fc dozlarda kullan\u0131ld\u0131\u011f\u0131nda, derin travmalara ba\u011fl\u0131 psikolojik bozukluklar ya\u015fayan ki\u015filere yard\u0131mc\u0131 olabilir. Sa\u011fl\u0131kl\u0131 g\u00f6n\u00fcll\u00fcler \u00fczerinde yap\u0131lan ara\u015ft\u0131rmalar, 75 ila 125 miligram aras\u0131nda de\u011fi\u015fen dozlarda MDMA’n\u0131n, pozitif ruh hali, empati, g\u00fcven ve sosyal duygu art\u0131\u015f\u0131n\u0131 te\u015fvik etti\u011fini g\u00f6stermektedir. Bu etkiler, beynin serotonin, dopamin ve noradrenalin gibi baz\u0131 kimyasal habercilerin artan sal\u0131n\u0131m\u0131na ba\u011fl\u0131d\u0131r.<\/p>\n
Sarho\u015fluk s\u0131ras\u0131nda, MDMA yeni an\u0131lar\u0131 kodlama yetene\u011fini ge\u00e7ici olarak de\u011fi\u015ftirir, bu da olumsuz an\u0131lar\u0131n canl\u0131l\u0131\u011f\u0131n\u0131 azaltarak travmalar\u0131n tedavisini kolayla\u015ft\u0131rabilir. Bununla birlikte, bireyleri \u00f6nerilere veya yanl\u0131\u015f bilgilere kar\u015f\u0131 daha savunmas\u0131z hale getirmez. \u0130mpuls kontrol\u00fc gibi y\u00fcr\u00fct\u00fcc\u00fc i\u015flevler genel olarak korunur, ancak motor koordinasyon ve bili\u015fsel esneklikte hafif azalma olabilir.<\/p>\n
Bu etkiler, metabolizma, ba\u011f\u0131\u015f\u0131kl\u0131k yan\u0131t\u0131, ila\u00e7 etkile\u015fimleri ve kullan\u0131m ba\u011flam\u0131na g\u00f6re de\u011fi\u015fir. Al\u0131m sonras\u0131nda, beynin kimyasal habercilerindeki ge\u00e7ici azalmaya ba\u011fl\u0131 olarak, ruh halinde ve yorgunlukta ge\u00e7ici bir d\u00fc\u015f\u00fc\u015f ya\u015fanabilir. Terap\u00f6tik bir ortamda, bu \u00f6zellikler hasta ile terapist aras\u0131ndaki ili\u015fkiyi g\u00fc\u00e7lendirebilir, b\u00f6ylece ac\u0131 verici an\u0131lar\u0131 ele almak i\u00e7in gerekli olan a\u00e7\u0131kl\u0131\u011f\u0131 ve g\u00fcveni te\u015fvik edebilir.<\/p>\n
Ancak, MDMA’n\u0131n terapi s\u0131ras\u0131nda kullan\u0131m\u0131 titiz bir g\u00f6zetim gerektirir. Bilin\u00e7 durumundaki de\u011fi\u015fiklik nedeniyle hastalar, duygusal ba\u011f\u0131ml\u0131l\u0131klara veya k\u00f6t\u00fcye kullan\u0131ma kar\u015f\u0131 daha savunmas\u0131z olabilirler. Ayr\u0131ca, al\u0131m sonras\u0131 yorgunluk veya hafif depresif ruh hali gibi yan etkilerin \u00f6nceden tahmin edilmesi ve dikkatle y\u00f6netilmesi gerekmektedir.<\/p>\n
\u00c7al\u0131\u015fmalar, dozlar\u0131n bireysel \u00f6zelliklere, cinsiyet veya genetik gibi fakt\u00f6rlere g\u00f6re uyarlanmas\u0131n\u0131n \u00f6nemini vurgulamaktad\u0131r, b\u00f6ylece faydalar en \u00fcst d\u00fczeye \u00e7\u0131kar\u0131l\u0131rken riskler en aza indirgenir. Son olarak, MDMA’n\u0131n terap\u00f6tik protokollere entegrasyonu, tedavinin g\u00fcvenli\u011fini ve etkinli\u011fini sa\u011flamak i\u00e7in s\u0131k\u0131 kurallar \u00e7er\u00e7evesinde yap\u0131lmal\u0131d\u0131r.<\/p>\n
DOI\u00a0:<\/strong> https:\/\/doi.org\/10.1038\/s41380-026-03602-7<\/a><\/p>\n Titre\u00a0:<\/strong> Subjective and neurocognitive profiling of clinical doses of 3,4-methylenedioxymethamphetamine (MDMA) in healthy volunteers: implications for therapeutic use<\/p>\n Revue : <\/strong> Molecular Psychiatry<\/p>\n \u00c9diteur : <\/strong> Springer Science and Business Media LLC<\/p>\n Auteurs : <\/strong> Johannes G. Ramaekers; Kim P. C. Kuypers; Franz X. Vollenweider<\/p>\n","protected":false},"excerpt":{"rendered":" MDMA, psikolojik travmalar\u0131n tedavisini d\u00f6n\u00fc\u015ft\u00fcrebilir mi? MDMA, \u00f6forik ve empatik etkileriyle bilinen bir madde, t\u0131bbi alanda terap\u00f6tik potansiyeli nedeniyle giderek daha fazla ilgi g\u00f6rmektedir. Kontroll\u00fc dozlarda kullan\u0131ld\u0131\u011f\u0131nda, derin travmalara ba\u011fl\u0131 psikolojik bozukluklar ya\u015fayan ki\u015filere yard\u0131mc\u0131 olabilir. Sa\u011fl\u0131kl\u0131 g\u00f6n\u00fcll\u00fcler \u00fczerinde yap\u0131lan ara\u015ft\u0131rmalar, 75 ila 125 miligram aras\u0131nda de\u011fi\u015fen dozlarda MDMA’n\u0131n, pozitif ruh hali, empati, g\u00fcven ve… Okumaya devam et MDMA, psikolojik travmalar\u0131n tedavisini d\u00f6n\u00fc\u015ft\u00fcrebilir mi?<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6,2],"tags":[],"class_list":["post-23","post","type-post","status-publish","format-standard","hentry","category-insan-insani","category-saglik","entry"],"_links":{"self":[{"href":"https:\/\/psychiatryfoundation.com\/tr\/wp-json\/wp\/v2\/posts\/23","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/psychiatryfoundation.com\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/psychiatryfoundation.com\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/psychiatryfoundation.com\/tr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/psychiatryfoundation.com\/tr\/wp-json\/wp\/v2\/comments?post=23"}],"version-history":[{"count":1,"href":"https:\/\/psychiatryfoundation.com\/tr\/wp-json\/wp\/v2\/posts\/23\/revisions"}],"predecessor-version":[{"id":24,"href":"https:\/\/psychiatryfoundation.com\/tr\/wp-json\/wp\/v2\/posts\/23\/revisions\/24"}],"wp:attachment":[{"href":"https:\/\/psychiatryfoundation.com\/tr\/wp-json\/wp\/v2\/media?parent=23"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/psychiatryfoundation.com\/tr\/wp-json\/wp\/v2\/categories?post=23"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/psychiatryfoundation.com\/tr\/wp-json\/wp\/v2\/tags?post=23"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}